fashion -WSS

fashion

author：knowledge 2025-10-01 23:05:10 - browse：361

Maze Therapeutics CEO Jason Coloma Courtesy

After seeing its last deal go bust in the face of regulatory scrutiny, Maze Therapeutics has found another suitor for its experimental Pompe disease treatment.

Bay Area-based Maze and Shionogi said Friday that the Japanese pharma company had licensed the drug, called MZE001, with an upfront payment of $150 million. The global deal includes additional, undisclosed payments if the oral medication, which is in clinical testing, meets certain regulatory and commercial goals.

Last year, Sanofi, the French pharma giant, was set to pay $150 million in cash and stock to Maze before the transaction fell apart.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Bird flu researchers hone in on Finland’s mink farms

knowledge

WSS

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Idaho college killings prosecutors challenge defense's grand jury claims

Mark Cuban is blaming the wrong people for high drug costs

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Bird flu researchers hone in on Finland’s mink farms

Idaho college killings prosecutors challenge defense's grand jury claims

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Continuity nursing helped my family in our darkest PICU moments

Mark Cuban is blaming the wrong people for high drug costs

What does generative AI mean for health care? We asked experts

Novo Nordisk touts Wegovy study, but still struggling with supply

Continuity nursing helped my family in our darkest PICU moments

Illinois Supreme Court finds assault weapons ban constitutional

Continuity nursing helped my family in our darkest PICU moments

Dozens dead from Maui wildfires: What we know about the victims

At least 13 dead in Texas as scorching temps continue

Achieving telehealth equity for people with hearing loss

hotspot

Illinois Supreme Court finds assault weapons ban constitutional

Idaho college killings prosecutors challenge defense's grand jury claims

BMS, looking to build heart drug business, turns to AI for diagnosis

Hospitals are dialing back on venture capital investing

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Louisiana bill approved classifying abortion pills as controlled substances

explore

explore

knowledge

hotspot